Form 4 Filing for Beam Therapeutics Inc. - Guindo Chirfi Option Grant

This filing details a stock option grant to Guindo Chirfi, a director at Beam Therapeutics Inc. On June 3, 2026, Mr. Chirfi was granted 19,676 stock options with an exercise price of $29.55 per share. The options are set to expire on June 3, 2036. Vesting occurs in full on the earlier of the first anniversary of the grant date or immediately prior to the next annual stockholders meeting, contingent upon continued service. The transaction is reported on Form 4, indicating a change in beneficial ownership.